drugset / Trial / NCT01575899
Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori
RandomizedParallel-groupOpen-labelTreatment
Summary
This prospective controlled randomized open-label clinical trial is designed to determine the eradication rate of 7-day levofloxacin, amoxicillin/clavulanate and rabeprazole regimen compared with 7-day standard triple therapy for adults infected with Helicobacter pylori in Eastern Taiwan.
Timeline
- Start
- 2007-12
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Amoxicillin/clavulanate | Unknown | 125 mg | — |
| Subject | Amoxicillin/clavulanate | Unknown | 875 mg | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Levofloxacin | Small molecule | 500 mg | — |
| Comparator | Rabeprazole | Small molecule | 20 mg | — |